Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects who has been using reusable device growth hormone injection in recent 3 months at least for 6 weeks~* Subjects who meets the indication of EutropinPen inj.~Exclusion Criteria:~* Subjects who has diseases below on screening visit~  * Diabetes~ * Malignant tumor~ * Epiphyseal closure~ * Chronic kidney disease (recieved kidney transplantation)~ * Acute respitory failure

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 15 Years
- Healthy Volunteers: f

Study Arms:
- Eutropin pen inj. (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).